Biotech News
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
investors.maxcyte.com2026-05-06 14:58 EST
ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced the launch of